ORIGINAL ARTICLE
Close relationship between TAZhigh/SOX2high co-localization and metastasis in oral squamous cell carcinoma
 
More details
Hide details
1
Department of Diagnostic Techniques in Pathomorphology, Chair of Oncology, Medical University of Lodz, Poland
 
2
Department of Pathomorphology, Chair of Oncology, Medical University of Lodz, Poland
 
3
Department of Diagnostic Techniques in Pathomorphology, Chair of Oncology, Medical University of Lodz (student), Poland
 
4
The Central Clinical Hospital of the Medical University of Lodz, Poland
 
 
Submission date: 2021-01-06
 
 
Acceptance date: 2021-05-01
 
 
Publication date: 2022-01-19
 
 
Pol J Pathol 2021;72(3):229-236
 
KEYWORDS
TOPICS
ABSTRACT
There is growing evidence which indicates that the development and the biological features of cancer such as the invasion, metastases and recurrence are related to the presence and behavior of the cancer stem cells (CSC). However, the regulatory mechanisms underlying CSCs-specific properties are poorly determined, the Hippo pathway has emerged as a fundamental regulator underlying CSCs stemness.
Immunohistochemical method was used to examine the immunoexpression of SOX2, TAZ and α-SMA in oral squamous cells carcinomas: with metastases –
OSCC M+ (n = 42), and without metastases – OSCC M– (n = 44), and 17 control cases.
The immunoexpression of SOX2, TAZ and α-SMA was significantly increased in both group of OSCC in comparison to control groups. Moreover, significantly increased TAZ and α-SMA immunoexpression were found in OSCC M+ compared to OSCC M-. In OSCC M+ and OSCC M- groups there were statistically significant correlations between the immunoexpression of TAZ vs SOX2 (r = 0.56, p < 0.001; r = 0.33, p < 0.03 respectively), and TAZ vs α-SMA (r = 0.64, p < 0.001; r = 0.67, p < 0.001 respectively). Moreover, there was statistically significant association between TAZhigh/SOX2high coexistent immunoexpression and the presence of metastases (p < 0.007).
Our results may suggest that SOX2 and TAZ could potentially cooperate and contribute to process of metastasis, especially in cases with TAZhigh/SOX2high expression.
REFERENCES (28)
1.
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-E386.
 
2.
Schmidt Jensen J, Jakobsen KK, Mirian C, et al. The Copenhagen Oral Cavity Squamous Cell Carcinoma database: protocol and report on establishing a comprehensive oral cavity cancer database. Clin Epidemiol 2019; 19: 733-741.
 
3.
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45: 309-316.
 
4.
Rodini CO, Lopes NM, Lara VS, Mackenzie IC. Oral cancer stem cells – properties and consequences. J Appl Oral Sci 2017; 25: 708-715.
 
5.
Kaveh K, Nathan L, Reigh-Yi L. The role of cancer stem cells in head and neck squamous cell carcinoma and its clinical implications. In: Dmitry Bulgin E (ed.). New Aspects in Molecular and Cellular Mechanisms of Human Carcinogenesis. Saint Louis, MO, InTech 2016; 97-113.
 
6.
Ayob AZ, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci 2018; 25: 20.
 
7.
Chou MY, Hu FW, Yu CH, Yu CC. Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells. Oral Oncol 2015; 51: 31-39.
 
8.
Fu TY, Hsieh IC, Cheng JT, et al. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression. J Oral Pathol Med 2016; 45: 89-95.
 
9.
Kamachi Y, Uchikawa M, Kondoh H. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 2008; 16: 182-187.
 
10.
Kim J, Chu J, Shen X, Wang J, Orkin S. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008; 132: 1049-1110.
 
11.
Li Z, Wang Y, Zhu Y, et al. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer. Mol Oncol 2015; 9: 1091-1105.
 
12.
Santucci M, Vignudelli T, Ferrari S, et al. The Hippo pathway and YAP/TAZ-TEAD protein-protein interaction as targets for regenerative medicine and cancer treatment. J Med Chem 2015; 58: 4857-4873.
 
13.
Zhang H, Liu CY, Zha ZY, et al. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem 2009; 284: 13355-13362.
 
14.
Barnes L, Everson JW, Reichart P, et al. World Health Organization Classification of Tumours. Pathology and Genetics Head and Neck Tumours. IARC Press Lyon 2005; 168-176.
 
15.
Neumann J, Bahr F, Horst D, et al. SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer 2011; 11: 518.
 
16.
Yang F, Gao Y, Geng J, et al. Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer. Int J Clin Exp Pathol 2013; 6: 2846-2854.
 
17.
Qiao B, He B, Cai J, Yang W. The expression profile of Oct4 and Sox2 in the carcinogenesis of oral mucosa. Int J Clin Exp Pathol 2013; 7: 28-37.
 
18.
Yuan P, Kadara H, Behrens C, et al. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. PLoS One 2010; 9; 5: 9112.
 
19.
Li XL, Eishi Y, Bai YQ, et al. Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J Oncol 2014; 24: 257-263.
 
20.
Ren ZH, Zhang CP, Ji T. Expression of SOX2 in oral squamous cell carcinoma and the association with lymph node metastasis. Oncol Lett 2016; 11: 1973-1979.
 
21.
Michifuri Y, Hirohashi Y, Torigoe T, et al. High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis. Pathol Int 2012; 62: 684-689.
 
22.
Züllig L, Roessle M, Weber C, et al. High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity. Eur J Cancer 2013; 49: 1915-1922.
 
23.
Baghai Naini F, Aminishakib P, Abdollahi A, et al. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non-Tumor Tissue. Asian Pac J Cancer 2019; 20: 1649-1654.
 
24.
Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011; 13: 877-883.
 
25.
Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer 2013; 13: 246-257.
 
26.
Khosravi A, Jafari SM, Asadi J. Knockdown of TAZ decrease the cancer stem properties of ESCC cell line YM-1 by modulation of Nanog, OCT-4 and SOX2. Gene 2020; 145207.
 
27.
Bartucci M, Dattilo R, Moriconi C, et al. TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells. Oncogene 2015; 34: 681-690.
 
28.
Lei QY, Zhang H, Zhao B, et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 2008; 28: 2426-2436.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top